Tao Hu (left), founder and chief scientist of NeuroXess, shakes hands with a patient using a thought-controlled exoskeleton at a clinical rehabilitation center in Shanghai. CHINA DAILY
Chinese brain-computer interface company NeuroXess is gearing up for what it sees as the next phase of the industry: mass production.
The startup plans to begin operating a 14,300-square-meter manufacturing facility in Jiangxi province in the second half, a move NeuroXess founder and chief scientist Tiger Tao Hu said will help transform BCIs from experimental technologies tested on dozens of patients into products that can be delivered at an industrial scale.
This also reflects the company's dual-core strategy of "research and development in Shanghai, production in Jiangxi", Tao said in an exclusive interview with China Daily.
Such efforts come as BCIs, which create direct communication pathways between the human brain and technology such as a computer or artificial limb, attract growing global attention from investors, governments and technology companies.
